Renalytix plc - ADS (RNLXY)

CUSIP: 75973T101

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / ADS
Total 13F shares
3,444,225
Share change
-1,353,289
Total reported value
$6,439,824
Put/Call ratio
107%
Price per share
$1.87
Number of holders
20
Value change
-$1,916,928
Number of buys
9
Number of sells
15

Quarterly Holders Quick Answers

What is CUSIP 75973T101?
CUSIP 75973T101 identifies RNLXY - Renalytix plc - ADS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Renalytix plc - ADS (RNLXY) as of Q4 2022

As of 31 Dec 2022, Renalytix plc - ADS (RNLXY) was held by 20 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,444,225 shares. The largest 10 holders included GILDER GAGNON HOWE & CO LLC, Pentwater Capital Management LP, PINNACLE ASSOCIATES LTD, Tejara Capital Ltd, CI Private Wealth, LLC, GOFEN & GLOSSBERG LLC /IL/, LAZARD ASSET MANAGEMENT LLC, JPMORGAN CHASE & CO, MORGAN STANLEY, and StoneX Group Inc.. This page lists 20 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.